Nascent Biotech Inc.
NBIODelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622057
Nascent Biotech Inc. was delisted in 2024; its insiders filed their last Form 4 on Jul 2, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Holders of 5% or more of NBIO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nascent Biotech Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Nascent Biotech Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Nascent Biotech Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2024 | YA II PN, Ltd. | 13G/AOld format | – | – | – | SEC |
| Apr 14, 2023 | Burke Robert David | 13DOld format | – | New | – | SEC |
| Jan 3, 2023 | YA II PN, Ltd. | 13G/AOld format | – | – | – | SEC |
| Sep 1, 2022 | YA II PN, Ltd. | 13GOld format | – | New | – | SEC |
| Jun 21, 2021 | Lorio Sidney J Jr | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nascent Biotech Inc. shares.
No Form 144 notices for Nascent Biotech Inc. are on file.